Vinca rosea

this drug is very good in type 2 diabetic patients ,and also very effective preventing cancerous growth ,i was introduced to the drug as good anti diabetic medicine ,but when i digged deep found that it is very effective in cancer .
Vinca rosea is grown throughout India. It has certain properties to soothe the nervous system, and acts against restlessness. It also prevents the growth of cancerous cells. It is also an anti-depressant and relieves muscle pain. It has sedative and tranquilizing properties.

Though the white to light purple flowers are good to see, they smell very bad. In Malayalam, it is called savam nari poovu, which means it smells like a dead body.

Vinca Rosea is in the plant family apocynaceae

Family Name : APOCYNACEAE

Botanical Name : VINCA ROSEA

Common Name : PERIWINKLE, MADAGASCAR PERIWINKLE, SADABAHAR

Part Used : LEAVES, ROOTS

Habitat : Grows throughout India and found as an escape in waste places and sandy tracts.
i wanted back my claims with research results i have included this bit
The experimental activity of a new clinically confirmed antitumor compound,
Vincaleukoblastine (C46H58O9N4),(VLB) as the sulfate has been described. Greatest
activity was seen against the P-1534 acute lymphocytic leukemia in DBA/2 mice.
Late as well as early stages of this leukemia were significantly affected by this com
pound. No synergistic or additive effects have been observed in combination therapy
with other antitumor compounds.
A second indole-indoline alkaloid, leurosine, isomerie with VLB, has also been ob
tained from Vinca rosea Linn, with similar demonstrable experimental antitumor
activity.
Two other alkaloids, vin doline (CssHasOz) and catharan thine (C2iH2402N2), also
obtained from Vinca rosea, were devoid of antitumor activity singly or in equimolar
concentrations, but have been postulated as the biogenetic precursors of VLB and
leurosine.
Preliminary studies in vitro demonstrated that certain compounds were capable
of reversing the growth-inhibitory activity of VLB against human monocytic leu
kemia cells. These compounds were coenzyme A, aspartic acid, tryptophan, a-ketoglutaric
acid, ornithine, citrulline, arginine, and glutamic acid.
VLB and leurosine are representatives of a new class of clinically active antitumor
compounds which may interfere with the cellular metabolic pathways leading from
glutamic acid to urea, and from glutamic acid to the citric acid cycle.